EC

EcoR1 Capital Portfolio holdings

AUM $1.69B
This Quarter Return
+14.08%
1 Year Return
+7.54%
3 Year Return
+113.08%
5 Year Return
+306.58%
10 Year Return
+4,328.75%
AUM
$1.39B
AUM Growth
+$1.39B
Cap. Flow
+$46.9M
Cap. Flow %
3.38%
Top 10 Hldgs %
66.53%
Holding
65
New
17
Increased
7
Reduced
4
Closed
19

Top Buys

1
RLAY icon
Relay Therapeutics
RLAY
$136M
2
NRIX icon
Nurix Therapeutics
NRIX
$41.6M
3
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
$17.7M
4
BCEL
Atreca, Inc. Class A Common Stock
BCEL
$13.1M
5
STRO icon
Sutro Biopharma
STRO
$12.9M

Top Sells

1
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
$69.1M
2
RARE icon
Ultragenyx Pharmaceutical
RARE
$40.6M
3
CNST
Constellation Pharmaceuticals, Inc.
CNST
$25.2M
4
FATE icon
Fate Therapeutics
FATE
$21.3M
5
DNLI icon
Denali Therapeutics
DNLI
$17.7M

Sector Composition

1 Healthcare 97.04%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
XNCR icon
1
Xencor
XNCR
$580M
$176M 12.58% 4,547,072 – –
KURA icon
2
Kura Oncology
KURA
$686M
$141M 10.07% 4,608,529 – –
RLAY icon
3
Relay Therapeutics
RLAY
$619M
$136M 9.72% +3,200,649 New +$136M
PRTA icon
4
Prothena Corp
PRTA
$441M
$94.2M 6.71% 9,426,640 – –
MORF
5
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$77.6M 5.54% 2,839,884 +1,911 +0.1% +$52.2K
MRTX
6
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$77.1M 5.5% 464,298 +106,449 +30% +$17.7M
ORIC icon
7
Oric Pharmaceuticals
ORIC
$994M
$66.1M 4.71% 2,642,218 – –
RNA icon
8
Avidity Biosciences
RNA
$5.99B
$59.2M 4.22% 2,103,950 – –
ANAB icon
9
AnaptysBio
ANAB
$569M
$47.5M 3.39% 3,223,324 +148,310 +5% +$2.19M
NGNE icon
10
Neurogene
NGNE
$264M
$46.4M 3.31% 3,862,931 +326,247 +9% +$3.91M
AKUS
11
DELISTED
Akouos, Inc. Common Stock
AKUS
$45.2M 3.22% 1,975,984 – –
ASMB icon
12
Assembly Biosciences
ASMB
$190M
$41.9M 2.99% 2,548,382 -605,415 -19% -$9.95M
NRIX icon
13
Nurix Therapeutics
NRIX
$714M
$41.6M 2.97% +1,192,156 New +$41.6M
AMTI
14
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
$36.6M 2.61% 1,150,000 – –
BCEL
15
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$33.9M 2.42% 2,426,685 +937,500 +63% +$13.1M
GERN icon
16
Geron
GERN
$893M
$33.5M 2.39% 19,230,769 – –
STRO icon
17
Sutro Biopharma
STRO
$72.7M
$31.3M 2.23% 3,113,617 +1,285,125 +70% +$12.9M
RCUS icon
18
Arcus Biosciences
RCUS
$1.13B
$31M 2.21% 1,810,000 – –
SURF
19
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$23M 1.64% 3,333,177 -1,700,684 -34% -$11.7M
CYCN icon
20
Cyclerion Therapeutics
CYCN
$7.91M
$16.7M 1.19% 2,742,276 – –
KLRS
21
Kalaris Therapeutics, Inc. Common Stock
KLRS
$76.3M
$12.3M 0.88% +447,012 New +$12.3M
CBIO
22
Crescent Biopharma, Inc. Common Stock
CBIO
$200M
$11.4M 0.82% 3,725,150 +1,836,150 +97% +$5.64M
TNGX icon
23
Tango Therapeutics
TNGX
$747M
$8.29M 0.59% +800,000 New +$8.29M
VINC
24
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
$7.82M 0.56% +630,505 New +$7.82M
ALPN
25
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
$6.52M 0.46% +741,290 New +$6.52M
1
2 3